A romanian population isolate with high frequency of vitiligo and associated autoimmune diseases

Archives of Dermatology

Volumn 144, Issue 3, 2008, Pages 310-316

  Birlea, Stanca A ^a   Fain, Pamela R ^a,b   Spritz, Richard A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; COMMUNITY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; GENE SEGREGATION; HEREDITY; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR FAMILY; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEGREGATION ANALYSIS; VITILIGO;

EID: 41149116756     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.3.310     Document Type: Article

References (31)

1. Hann SK, Nordlund JJ, eds. Vitiligo. Oxford, England: Blackwell Science; 2000:3-6.
2. Nordlund JJ, Ortonne J-P, LePoole IC, et al. Vitiligo vulgaris. In: Nordlund JJ, Ortonne J-P, LePoole IC, et al, eds. The Pigmentary System. Malden, MA: Blackwell Publishers; 2006:551-598.
3. Howitz J, Brodthagen H, Schwartz M, Thompsen K. Prevalence of vitiligo: epidemiological survey of the Isle of Bornholm, Denmark. Arch Dermatol. 1977;113(1):47-52.
4. Das SK, Majumder PP, Chakraborty R, Majumdar TK, Halder B. Studies on vitiligo, I: epidemiological profile in Calcutta, India. Genet Epidemiol. 1985;2(1):71-78.
5. Lu T, Gao T, Wang A, Jin Y, Li Q, Li C. Vitiligo prevalence study in Shaanxi Province, China. Int J Dermatol. 2007;46(1):47-51.
6. Harsoulis P, Kanakouki-Tsakalidis F, Vyzantiadis A, Minas A, Cassimos C. Autoimmunity and vitiligo. Arch Dermatol. 1978;114(10):1554.
7. Ongenae K, Van Geel N, Naeyaert J-M. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16(2):90-100.
8. Le Poole IC, Wañkowicz-Kaliñska A, van den Wijngaard RM, Nickoloff BJ, Das PK. Autoimmune aspects of depigmentation in vitiligo. J Investig Dermatol Symp Proc. 2004;9(1):68-72.
9. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16(3):208-214.
10. Laberge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005;18(4):300-305.
11. Spritz RA. The genetics of vitiligo and associated autoimmune diseases. Pigment Cell Res. 2007;20(4):271-278.
12. Spritz RA. The genetics of generalized vitiligo. In: Nickoloff BJ, Nestle FO, eds. Dermatologic Immunity. Basel, Switzerland: S Karger AG. In press. Theophilopoulos AN, ed. Current Directions in Autoimmunity; vol 10.
13. Sheffied VC, Stone EM, Carmi R. Use of isolated inbred populations for identification of disease genes. Trends Genet. 1998;14(10):391-396.
14. Taïeb A, Picardo M; VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20(1):27-35.
15. Lange K, Cantor R, Horvath S, et al. MENDEL version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet. 2001;69(suppl.):A1886.
16. Birlea S, Pop A, Birlea M, Spritz RA. Vitiligo: prevalenţǎ semnificativǎ, agregare familialǎ si autoimunitate într-un izolat populaţional Maramuresean. Dermatovenerol. 2006;50:229-234.
17. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223-243.
18. Pozzilli P, DiMario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult). Diabetes Care. 2001;24(8):1460-1467.
19. Koopman RJ, Mainous AG III, Diaz VA, Geesey ME. Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med. 2005;3(1):60-63.
20. Jin Y, Birlea SA, Fain PR, Spritz RA. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol. 2007;127(11):2558-2562.
21. Liu JB, Li M, Yang S, et al. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol. 2005;30(4):327-331.
22. Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol. 1999;26(10):653-657.
23. Hann SK, Chun WH, Park YK. Clinical characteristics of progressive vitiligo. Int J Dermatol. 1997;36(5):353-355.
24. Mehta NR, Shah KC, Theodore C, Vyas VP, Patel AB. Epidemiological study of vitiligo in Surat area. Indian J Med Res. 1973;61(1):145-154.
25. Carnevale A, Zavala C, Castillo VD, Maldonado RR, Tamayo L. Analisis genetico de 127 families con vitiligo. Rev Invest Clin. 1980;32(1):37-41.
26. Hafez M, Sharaf L, El-Nabi SMA. The genetics of vitiligo. Acta Derm Venereol. 1983;63(3):249-251.
27. Bhatia PS, Mohan L, Pandey ON, Singh KK, Arora SK, Mukhija RD. Genetic nature of vitiligo. J Dermatol Sci. 1992;4(3):180-184.
28. Majumder PP, Das SK, Li CC. A genetical model for vitiligo. Am J Hum Genet. 1988;43(2):119-125.
29. Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet. 1994;55(5):981-990.
30. Arcos-Burgos M, Parodi E, Salgar M, et al. Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum Genet. 2002;110(4):334-342.
31. Sun X, Xu A, Wei X, et al. Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China. Int J Dermatol. 2006;45(10):1176-1181.